Menu
Cart 0
Global CRISPR Market

Global CRISPR Market - Forecasts from 2017 to 2022

  • $4,200.00
  • Publishing Date: August 2017
  • Format:
Sample Request

The Global CRISPR market is a growing industry with major investments from developed countries. Global genome editing market is witnessing high growth rate after the discovery of cutting-edge tool- “CRISPR”, a shorthand for “Clustered Regularly Interspaced Short Palindromic Repeats”. CRISPR-based tools are increasingly being adopted by the enterprises globally for new developments in fields like genome editing, genetic engineering, biotechnology, pharmaceutical, and agriculture. Global CRISPR market is estimated to grow at a CAGR of XX% during the forecast period to reach a total market size of US$XX billion by 2022.

By Products

CRISPR-based products are applicable to any system containing genome. Gene designing tools were launched by many firms in the market due to high target efficiency and wide applications. Design tools are the major product segment of the global CRISPR market, followed by CAS9 and G RNA in terms of market share. A major vendor, Thermo Fisher Scientific recently launched design tools based on CRISPR, to simplify its application in genome editing and gene synthesis.

By Applications

After the introduction of CRISPR-based tools for genome manipulations in Genetic Engineering, the segment is witnessing a significant growth. Applications of CRISPR-based tools in genetic engineering is expected to grow at the highest rate over the forecast period. G-RNA databases/libraries form a major segment of the global CRISPR market. Application of CRISPR-based tools in cell line editing and gene manipulations will also grow at a moderate rate over the next five years.

By Industry

CRISPR-based products have many applications across Biotechnology industry ranging from producing new genetically modified crops/organisms to drug discovery. CRISPR-based products are being widely adopted by different end users, as they are easily available and cost effective. The academic and research segment of the global CRISPR market will witness significant growth because of ongoing research and developmental activities on CRISPR-based tools.

By Regions

Globally, North America held the largest market share of the global CRISPR market in 2016. The US-based gene editing market is witnessing a robust growth of CRISPR-based technologies. Companies from Germany, Switzerland and other European countries are showing interest in CRISPR research and development by continuously investing in the global CRISPR-based tools along with many firms acquiring patent rights in specific regions for various CRISPR-based tools.

Competitive Insights

Genome editing, biotechnology, Agricultural crops, drug discovery are receiving huge investments from prominent firms. CRISPR Industry has several major players such as Addgene, CRISPR Therapeutics, GE Healthcare Dharmacon Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Thermo Fisher Scientific, Inc., and Transposagen Biopharmaceuticals, Inc. among others. Vendors of these solutions are exploring possibilities of various applications of CRISPR-CAs9 tool in gene therapy have raised more than US$ 500 million. Bayer and CRISPR Therapeutics collaborated to form a major joint venture Casebia Therapeutics in 2016 to explore possibilities of curing genetic diseases using CRISPR-based tools.

Segmentation

Global CRISPR market is segmented on basis of products, application, industry verticals and geography/regions.

  • By Products
    • Design Tools
    • Plasmid and Vector
    • Cas9 and g-RNA
    • Delivery System products
  • By Applications
    • Genome Editing
    • Genetic Engineering
    • G RNA Database/Gene Library development
    • GM organisms and Crops
    • Cell Line Editing
    • Human Stem Cells
  • By Industry
    • Biotechnology
    • Pharmaceuticals
    • Academic and Research Institutes
    • Others
  • By Regions
    • Americas
      • North America
        • US
        • Canada
        • Others
      • South America
    • Europe Middle East and Africa
      • UK
      • Germany
      • Italy
      • Spain
      • Rest of Middle East and Africa
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia

Key questions answered by the report

  • What will be the Global CRISPR Market size from 2017 to 2022?
  • How are the major drivers and restraints affecting the Global CRISPR Market growth and the opportunities which exist for key vendors?
  • Which segment and region will drive or lead the market growth and why?
  • A comprehensive analysis of competitive landscape and key market participants’ behavior
  • Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1. Market Overview and Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Porter's Five Forces
4.6. Supplier Outlook
4.7. Industry Outlook
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis
5. CRISPR Market Forecast by Products (US$ Billion)
5.1. Design Tools Products
5.1.1. Market Size and Forecast to 2022
5.2. Plasmid and Vector Products
5.2.1. Market Size and Forecast to 2022
5.3. CAS9 and g- RNA Products
5.3.1. Market Size and Forecast to 2022
5.4. Delivery System Products
5.4.1. Market Size and Forecast to 2022
6. Global CRISPR Market Forecast by Applications (US$ Billion)
6.1. Genome Editing
6.1.1. Market Size and Forecast to 2022
6.2. Genetic engineering
6.2.1. Market Size and Forecast to 2022
6.3. G RNA Database/Gene Library development
6.3.1. Market Size and Forecast to 2022
6.4. GM organisms and Crops
6.4.1. Market Size and Forecast to 2022
6.5. Cell Line Editing
6.5.1. Market Size and Forecast to 2022
6.6. Human Stem Cells
6.6.1. Market Size and Forecast to 2022
7. CRISPR Market Forecast by Industry Verticals (US$ Billion)
7.1. Biotechnology
7.1.1. Market Size and Forecast to 2022
7.2. Pharmaceuticals
7.2.1. Market Size and Forecast to 2022
7.3. Academic and Research Institutes
7.3.1. Market Size and Forecast to 2022
7.4. Others
7.4.1. Market Size and Forecast to 2022
8. CRISPR Market Forecast by Regions (US$ Billion)
8.1. Americas
8.1.1. North America
8.1.1.1. US
8.1.1.1.1. Market Size and Forecast to 2022
8.1.1.2. Canada
8.1.1.2.1. Market Size and Forecast to 2022
8.1.1.3. Others
8.1.1.3.1. Market Size and Forecast to 2022
8.1.2. South America
8.1.2.1.1. Market Size and Forecast to 2022
8.2. Europe Middle East and Africa
8.2.1. UK
8.2.1.1.1. Market Size and Forecast to 2022
8.2.2. Germany
8.2.2.1.1. Market Size and Forecast to 2022
8.2.3. Italy
8.2.3.1.1. Market Size and Forecast to 2022
8.2.4. Spain
8.2.4.1.1. Market Size and Forecast to 2022
8.2.5. Rest of Middle East and Africa
8.2.5.1.1. Market Size and Forecast to 2022
8.3. Asia Pacific
8.3.1. India
8.3.1.1.1. Market Size and Forecast to 2022
8.3.2. China
8.3.2.1.1. Market Size and Forecast to 2022
8.3.3. Japan
8.3.3.1.1. Market Size and Forecast to 2022
8.3.4. Australia
8.3.4.1.1. Market Size and Forecast to 2022
8.3.5. Others
8.3.5.1.1. Market Size and Forecast to 2022
9. Competitive Analysis
9.1. Market Share Analysis
9.2. Investment Analysis
9.3. Recent Deals
9.4. Strategies of Key Player
10. Major Global Companies
10.1. Addgene
10.1.1. Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. CRISPR THERAPEUTICS
10.2.1. Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3. Editas Medicine
10.3.1. Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. Egenesis Inc.
10.4.1. Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5. GE Healthcare Dharmacon Inc.
10.5.1. Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. GenScript Biotech Corporation
10.6.1. Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Horizon Discovery Group plc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. Integrated DNA Technologies, Inc.
10.8.1. Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. Intellia Therapeutics, Inc.
10.9.1. Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. Lonza Group
10.10.1. Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
10.11. New England Biolabs
10.11.1. Overview
10.11.2. Financials
10.11.3. Products and Services
10.11.4. Recent Developments
10.12. OriGene Technologies, Inc.
10.12.1. Overview
10.12.2. Financials
10.12.3. Products and Services
10.12.4. Recent Developments
10.13. Precision Biosciences
10.13.1. Overview
10.13.2. Financials
10.13.3. Products and Services
10.13.4. Recent Developments
10.14. Thermo Fisher Scientific, Inc.
10.14.1. Overview
10.14.2. Financials
10.14.3. Products and Services
10.14.4. Recent Developments
10.15. Transposagen Biopharmaceuticals, Inc.
10.15.1. Overview
10.15.2. Financials
10.15.3. Products and Services
10.15.4. Recent Developments
List of Tables
List of Figures

Related Reports
Back to the top